This inventor holds 9 USPTO granted patents and 11 published patent applications and 1 EPO patent. Top assignees: Nanovation Therapeutics Inc., The University of British Columbia, Nanovision Therapeutics Inc.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
5 out of 6 
3 out of 962 
1 out of 1 Years Active: 2024-2026
Title: Innovations of Jayesh Kulkarni in Lipid Nanoparticle Technology
Introduction
Jayesh Kulkarni is a prominent inventor based in Vancouver, Canada, known for his significant contributions to the field of lipid nanoparticle technology. With a total of six patents to his name, Kulkarni has focused on developing advanced methods for delivering nucleic acid cargo molecules, which have important applications in biotechnology and medicine.
Latest Patents
Kulkarni's latest patents include innovative formulations of lipid nanoparticles. One notable patent describes a lipid nanoparticle that comprises a nucleic acid cargo molecule, sterol or a derivative present at elevated content, neutral lipid, an ionizable lipid, and a hydrophilic polymer-lipid conjugate. This formulation is designed to enhance the delivery efficiency of nucleic acids. Another significant patent outlines a method for producing unshielded lipid nanoparticles, which addresses previous challenges related to particle aggregation. This formulation includes a nucleic acid cargo molecule, sterol at a content of at least 12 mol %, and a neutral lipid, among other components.
Career Highlights
Throughout his career, Jayesh Kulkarni has worked with notable organizations such as Nanovation Therapeutics Inc. and the University of British Columbia. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in lipid nanoparticle technology.
Collaborations
Kulkarni has collaborated with talented individuals such as Daniel Kurek and Dominik Witzigmann. These partnerships have fostered innovation and have been instrumental in advancing the research and development of lipid nanoparticles.
Conclusion
Jayesh Kulkarni's work in lipid nanoparticle technology exemplifies the impact of innovative thinking in the field of biotechnology. His patents and collaborations continue to pave the way for advancements in the delivery of nucleic acids, showcasing his role as a key inventor in this area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile